Schedule 13G ownership disclosure
AERIE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00771V108
Event date: 2019-08-12
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,672,714
- Percent of class
- 3.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-040173
- Form type
- SC 13G
- Filer
- AERIE PHARMACEUTICALS INC
- CIK
- CIK 1337553
- Filed
- Aug 15, 2019
- Reporting period
- Aug 12, 2019
- Description
- Schedule 13G beneficial ownership